Expression of connexin 43 and E-cadherin protein and mRNA in non-small cell lung cancers in Chinese patients

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 2, 2013, Pages 639-643

  Zhao, Jun Qiang ^a,b   Sun, Fang Jie ^b   Liu, Shan Shan ^b   Yang, Jun ^b   Wu, Yu Quan ^c   Li, Gui Shan ^d   Chen, Qing Yong ^c   Wang, Jia Xiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c 117 Hospital of People's Liberation Army   (China)

^d Department of Psychiatry 91 Hospital of People's Liberation Army   (China)

Author keywords

Chinese patients; Connexin 43; E cadherin; Non small cell lung cancer

Indexed keywords

CADHERIN; CONNEXIN 43; GJA1 PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CHINA; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CHINA; CONNEXIN 43; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; LUNG; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84877671300     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.2.639     Document Type: Article

References (38)

1. Brehm R, Rüttinger C, Fischer P, et al (2006). Transition from preinvasive carcinoma in situ to seminoma is accompanied by a reduction of connexin 43 expression in Sertoli cells and germ cells. Neoplasia, 8, 499-509.
2. Chen JT, Cheng YW, Chou MC, et al (2003). The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in nonsmall cell lung cancer. Clin Cancer Res, 9, 4200-4.
3. Chen XF, Zhang HT, Qi QY, et al (2005). Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China. Lung Cancer, 48, 69-76.
4. Cronier L, Crespin S, Strale PO, et al (2009). Gap Junctions and Cancer: New Functions for an Old Story. Antioxid Redox Signal, 11, 323-38.
5. Dittmar T, Heyder C, Gloria-Maercker E, et al (2007). Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organspecific manner. Clin Exper Metastasis, 25, 11-32.
6. Fujimoto K, Nagafuchi A, Tsukita S, et al (1997). Dynamics of connexins, E-cadherin and alpha-catenin on cell membranes during gap junction formation. J Cell Sci, 110, 311-22.
7. Hattori Y, Fukushima M, Maitani Y (2007). Non-viral delivery of the connexin43 gene with histone deacetylase inhibitor to human nasopharyngeal tumor c ells enhances gene expressi on and inhibits in vivo tumor growth. Int J Oncol, 30, 1427-39.
8. Huang RP, Hossain MZ, Sehgal A, et al (1999). Reduced connexin43 expression in hig- grade human brain glioma cells. Surg Oncol, 70, 21-4.
9. Jeanes A, Gottardi CJ, Yap AS (2008). Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene, 27, 6920-9.
10. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
11. Jinn Y, Ichioka M, Marumo F (1998). Expression of connexin32 and connexin43 gap junction proteins and E- cadherin in human lung cancer. Cancer Lett, 127, 161- 9.
12. Jinn Y, Inase N (2010). Connexin43, E-Cadherin, β-Catenin and ZO-1 Expression, and Aberrant Methylation of the Connexin43 Gene in NSCLC. Anticancer Res, 30, 2271-8.
13. 2+ in mouse epidermal cells is controlled by E-cadherin. J Cell Biol, 114, 545-55.
14. Kato Y, Hirano T, Yoshida K, et al (2005). Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium. Lung Cancer, 48, 323-30.
15. King TJ, Bertram JS (2005). Connexins as targets for cancer chemoprevention and chemotherapy. Biochim Biophys Acta, 1719, 146-60.
16. Kobayashi H, Boelte KC, Lin PC (2007). Endothelial Cell Adhesion Molecules and Cancer Progression. Curr Med Chem, 14, 377-86.
17. Laird DW (2006). Life cycle of connexins in health and disease. J Biochem, 394, 527-43.
18. Laird DW, Fistouris P, Batist G, et al (1999). Deficiency of connexin43 gap junction is an independent marker for breast tumors. Cancer Res, 59, 4101-10.
19. Langlois S, Cowan KN, Shao Q, et al (2010). The tumor-suppressive function of connexin43 in keratinocytes is mediated in part via interaction with caveolin-1. Cancer Res, 70, 4222-32.
20. Losa D, Chanson M, Crespin S (2011). Connexins as therapeutic targets in lung disease. Expert Opin Ther Targets, 15, 989- 1002.
21. Makrilia N, Kollias A, Manolopoulos L, et al (2009). Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest, 27, 1023-37.
22. Lachlan E, Shao Q, Wang HL, et al (2006). Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res, 66, 9886-94.
23. Mesnil M, Crespin S, Avanzo JL, et al (2005). Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta, 1719, 125-45.
24. Murray SA, Davis K, Fishman LM, et al (2000). Alpha connexin43 gapjunction are decreased in human adrenocortical tumors. J Clin Endocrinol Metab, 85, 890-5.
25. Musil B, Linda S, Gerald M, et al (1990). Differential phosphorylation of gap junction protein connexin43 in junctional communication- competent and different cell lines. J Cell Biol, 111, 20777-9.
26. Naus CC, Laird DW (2010). Implications and challenges of connexin connections to cancer. Nat Rev Cancer, 10, 435-41.
27. Ogawa K, Pitchakarn P, Suzuki S, et al (2012). Silencing of connexin 43 suppresses invasion, migration and lung metastasis of rat hepatocellular carcinoma cells. Cancer Sci, 103, 860-7.
28. Parkin DM (2001). Global cancer statistics in the year 2000. Lancet Oncol, 2, 533-43.
29. 2+dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. EMBO J, 18, 1738-47.
30. Plante I, Stewart MK, Barr K, et al (2011). Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease. Oncogene, 30, 1681-92.
31. Proksch E, Brandner JM, Jensen JM (2008). The skin: an indispensable barrier. Exper Dermatol, 17, 1063-72.
32. Smythe W, Williams J, Wheelock M, et al (1999). Cadherin and catenin expression in normal bronchial epithelium and non-small cell lung cancer. Lung Cancer, 24, 157-68.
33. Sohl G, Willecke K (2004). Gap junctions and the connexin protein family. Cardiovasc Res, 62, 228-32.
34. Solan JL, Lampe PD (2009). Connexin43 phosphorylation-structural changes and biological effects. J Biochem, 419, 261-72.
35. Tomai E, Brownell HL, Tufescu TV, et al (1999). Gap junctional intercellular communication in cultured human lung carcinoma cells. Lung Cancer, 23, 223-31.
36. Wheelock MJ, Shintani Y, Maeda M, et al (2008). Cadherin switching. J Cell Sci, 121, 727-735.
37. Xu HT, Li QC, Zhang YX, et al (2008). Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells. Folia Histochem Cytobiol, 46, 315-21.
38. Yamasaki H, Krutovskikh V, Mesnil M, et al (1999). Role of connexin (gap junction) genes in cell growth control and carcinogenesis. CR Acad Sci 3, 322, 151-9.